1.
Drug Discov Today
; 26(1): 44-55, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33137484
RESUMO
Intravitreally injected antibody-based medicines have revolutionised the treatment of retinal disease. Bispecific and dual-functional antibodies and therapeutic proteins have the potential to further increase the efficacy of intraocular medicines.
